Characterization of aberrant pathways across human cancers
about
Cancer research in the era of next-generation sequencing and big data calls for intelligent modeling.Revealing Biological Pathways Implicated in Lung Cancer from TCGA Gene Expression Data Using Gene Set Enrichment Analysis.A multilevel pan-cancer map links gene mutations to cancer hallmarks.Chronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristicsPersonalized medicine in hematology - A landmark from bench to bedPetri Net computational modelling of Langerhans cell Interferon Regulatory Factor Network predicts their role in T cell activationModeling and simulation of multi-scale environmental systems with Generalized Hybrid Petri Nets
P2860
Q30401435-EA62C718-3A2D-41E0-B7B5-78636E9870C6Q30880346-1CABE932-4BAA-4963-B11E-0AB168D2992EQ36121343-0C4244AC-48EA-492B-B59B-88BE76A240E5Q36814056-D9B54033-5DB7-4A18-894E-72F07DB5FA19Q38263199-A438D433-42F8-4EBE-BFA0-D31B20B37F5FQ38848941-6FC54534-CCEF-4B8C-B8DA-42FDD3BCA024Q57898069-898FD667-1DA1-4D51-BD28-911A3EB7E951
P2860
Characterization of aberrant pathways across human cancers
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Characterization of aberrant pathways across human cancers
@ast
Characterization of aberrant pathways across human cancers
@en
type
label
Characterization of aberrant pathways across human cancers
@ast
Characterization of aberrant pathways across human cancers
@en
prefLabel
Characterization of aberrant pathways across human cancers
@ast
Characterization of aberrant pathways across human cancers
@en
P2093
P2860
P1433
P1476
Characterization of aberrant pathways across human cancers
@en
P2093
Antti Ylipää
Matti Nykter
Olli Yli-Harja
P2860
P2888
P356
10.1186/1752-0509-7-S1-S1
P478
P577
2013-08-12T00:00:00Z
P6179
1078817705